HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emil A Tanghetti Selected Research

Rosacea (Acne Rosacea)

4/2024Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.
1/2021Oxymetazoline and Energy-Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open-Label, Interventional Study.
6/2018Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
3/2018Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
1/2018WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.
6/2017The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.
1/2015Optimizing the use of topical brimonidine in rosacea management: panel recommendations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emil A Tanghetti Research Topics

Disease

18Acne Vulgaris
05/2024 - 02/2002
7Rosacea (Acne Rosacea)
04/2024 - 01/2015
7Erythema
09/2023 - 01/2015
7Psoriasis (Pustulosis Palmaris et Plantaris)
03/2023 - 08/2009
4Cicatrix (Scar)
12/2017 - 07/2003
1Pruritus (Itching)
09/2023
1Pain (Aches)
01/2020
1Disease Progression
06/2018
1Actinic Keratosis
11/2015
1Inflammation (Inflammations)
09/2013
1Telangiectasis (Telangiectasia)
02/2012
1AIDS-Related Complex (ARC)
02/2011
1Lentigo (Lentiginosis)
02/2005
1Hyperpigmentation
02/2005
1Vitiligo
02/2003

Drug/Important Bio-Agent (IBA)

14tazarotene (Tazorac)FDA Link
12/2023 - 02/2002
6halobetasol (ulobetasol)FDA LinkGeneric
03/2023 - 08/2018
5Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 01/2009
5RetinoidsIBA
05/2024 - 01/2009
5Benzoyl PeroxideFDA LinkGeneric
05/2024 - 02/2002
4clindamycin phosphate (Clindets)FDA LinkGeneric
05/2024 - 02/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
03/2023 - 08/2009
4OxymetazolineFDA Link
01/2021 - 01/2018
3Adapalene (Differin)FDA LinkGeneric
05/2024 - 01/2022
2EmulsionsIBA
12/2023 - 01/2020
2GelsIBA
05/2023 - 01/2022
2MucinsIBA
11/2016 - 01/2016
2CollagenIBA
11/2016 - 01/2016
1Clindamycin (Cleocin)FDA LinkGeneric
05/2024
1A-factor (Streptomyces)IBA
12/2023
1Anti-Infective Agents (Microbicides)IBA
12/2023
1Drug CombinationsIBA
01/2022
1Therapeutic UsesIBA
08/2021
1DapsoneFDA Link
06/2018
1gallium arsenide (GaAs)IBA
06/2018
1Fluorouracil (Carac)FDA LinkGeneric
11/2015
1Aminolevulinic Acid (Levulan)FDA Link
11/2015
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2015
1Brimonidine Tartrate (Alphagan)FDA LinkGeneric
01/2015
1Peptide Hydrolases (Proteases)FDA Link
09/2013
1LipidsIBA
09/2013
1NeuropeptidesIBA
09/2013
1CytokinesIBA
09/2013
1DefensinsIBA
09/2013
1calcipotriene (calcipotriol)FDA LinkGeneric
08/2009
1Vitamin DFDA LinkGeneric
08/2009
1Proteins (Proteins, Gene)FDA Link
07/2003
1Ointments (Pastes)IBA
02/2003
1Tacrolimus (Prograf)FDA LinkGeneric
02/2003
1Immunologic Factors (Immunomodulators)IBA
02/2003
1Erythromycin (Erycette)FDA LinkGeneric
02/2002
1Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2002

Therapy/Procedure

9Therapeutics
04/2024 - 02/2002
3Dye Lasers
02/2012 - 07/2003
1Tattooing
12/2017
1Lasers (Laser)
12/2017
1Rejuvenation
12/2017
1Skin Care
06/2017
1Baths
06/2017
1Aftercare (After-Treatment)
11/2016
1Solid-State Lasers
01/2016
1Photochemotherapy (Photodynamic Therapy)
11/2015